A phase II trial of subcutaneously administered recombinant human interleukin-2 in patients with relapsed/refractory thymoma. [electronic resource]

By: Contributor(s): Producer: 19961210Description: 179-84 p. digitalISSN:
  • 1067-5582
Subject(s): Online resources: In: Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy vol. 18
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

There are no comments on this title.

to post a comment.
Previous
Back to results
Next
Close